Oggelshausen, Germany

Ralf Otto

USPTO Granted Patents = 7 



Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2008-2014

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ralf Otto

Introduction

Ralf Otto, a distinguished inventor based in Oggelshausen, Germany, has made significant contributions to the field of biopharmaceutical production. With a portfolio of seven patents, Otto’s work has advanced methods for producing proteins in mammalian cells, particularly Chinese hamster ovary (CHO) cells. His innovative approaches aim to enhance the efficiency and automation of biopharmaceutical production processes.

Latest Patents

Among Otto's most notable patents is the method for producing proteins in CHO cells. This invention introduces a groundbreaking technique for selecting and recloning mammalian cells essential for biopharmaceutical production. The method emphasizes a high degree of automation and throughput, revolutionizing how these essential cells are cultivated. Additionally, he holds a patent related to neomycin-phosphotransferase genes and their application for selecting recombinant cells that produce elevated levels of desired gene products. This invention provides expression vectors that comprise modified neomycin phosphotransferase genes, enabling the effective preparation of heterologous gene products.

Career Highlights

Ralf Otto is currently associated with Boehringer Ingelheim Pharma GmbH & Co. KG, a prominent player in the pharmaceutical industry. His experience and expertise in biopharmaceutical research underscore his role in advancing innovative methodologies that impact the industry positively. Otto's dedication to research and development has positioned him as a key contributor in his field.

Collaborations

Throughout his career, Otto has collaborated with notable colleagues, including Juergen Fieder and Barbara Enenkel. These partnerships have fostered an environment of innovation, enhancing the development of technologies that facilitate biopharmaceutical production.

Conclusion

Ralf Otto's inventive spirit and contributions to the biopharmaceutical sector exemplify the impact of innovation in modern science. With a remarkable portfolio of patents and a commitment to research excellence, he continues to shape the landscape of protein production in mammalian cells. His work not only enriches the field of biopharmaceuticals but also inspires future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…